Juliette Martin

R6G narrows BmrA conformational spectrum for a more efficient use of ATP

This study shows that Rhodamine6G binding to BmrA narrows its conformational spectrum, enhancing ATP-dependent transport efficiency.

Challenges in predicting PROTAC-mediated Protein-Protein Interfaces with AlphaFold reveal a General Limitation on Small Interfaces

The paper evaluates AlphaFold's ability to predict PROTAC-mediated protein interfaces and finds it struggles with small interfaces, impacting PROTAC design.

Targeting a shared neoepitope derived from non-canonical translation of c-MYC oncogene in cancer cells

The paper identifies a shared neoepitope from non-canonical c-MYC translation in cancer cells that activates T cells to kill tumors without harming normal cells.

Rational Prediction of PROTAC-compatible Protein-Protein Interfaces by Molecular Docking

The paper presents a computational method to predict PROTAC-compatible protein-protein interfaces using docking and scoring techniques, achieving high accuracy in benchmark tests.

AlphaFold2 predicts interactions amidst confounding structural compatibility

The paper tests AlphaFold2's ability to predict protein interactions despite structural compatibility, finding it can distinguish interacting from non-interacting proteins with high accuracy.

Rescoring ensembles of protein-protein docking poses using consensus approaches

The paper improves protein-protein docking by combining consensus-based rescoring with the ZDOCK native scoring function, showing that interface size information is critical for better results.

Allosteric inhibition of adenylyl cyclase type 5 by G-protein: a molecular dynamics study

The paper uses molecular dynamics simulations to study how Gi inhibits AC5 and how ATP regulates this inhibition and stimulation.

A non-parametric method to compute protein-protein and protein-ligands interfaces. Application to HIV-2 protease-inhibitors complexes

The paper introduces a non-parametric method to compute protein-protein and protein-ligand interfaces and applies it to HIV-2 protease-inhibitor complexes.